Delivery Order SPE2DR25D3103-SPE2DR26F0F9Y

The Defense Logistics Agency awarded a $2,242.43 delivery order to AmerisourceBergen Drug Corp for 500 mg Dalvance vials, with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under the company's broader indefinite delivery contract vehicle with DLA. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...

The Defense Logistics Agency awarded a delivery order valued at $11,258.10 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic pharmaceutical product. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of October 31, 2025, and was issued on October 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...

The Defense Logistics Agency awarded a delivery order valued at $8,732.44 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, an antibiotic medication used in hospital and clinical settings. This competitively awarded, firm fixed-price delivery order was issued on September 10, 2025, with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside...

The Defense Logistics Agency awarded a $29,398.41 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat bacterial infections. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...

The Defense Logistics Agency awarded a $5,961.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dalvance 500 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be...

The Defense Logistics Agency awarded a delivery order valued at $20,469.30 to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...

The U.S. Defense Logistics Agency (DLA) awarded a $37,270.48 delivery order contract to Amerisourcebergen Drug Corp for the supply of DALVANCE 500 MG VIALS pharmaceutical products. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities from the vendor to support military treatment programs and facilities worldwide....

The Defense Logistics Agency awarded a delivery order valued at $10,284.07 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 15, 2025. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA Troop Support Medical. This...

The Defense Logistics Agency awarded a $7,575.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat bacterial skin infections. The contract, awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, represents a small-value order fulfilling immediate pharmaceutical supply needs for federal medical operations. The award was made on a non-set-aside, competitive basis to AmerisourceBergen's...

The Defense Logistics Agency (DLA) awarded a $40,847.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat serious bacterial skin infections. The award was made on January 23, 2026, with an ultimate completion date of January 26, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting...